K. Componeschi

TBCRC 030: A phase II study of preoperative cisplatin vs. paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker.

C. Perou, E. Winer, L. Trippa, 2020, Annals of oncology : official journal of the European Society for Medical Oncology.

Pre- and Postoperative Neratinib for HER2-Positive Breast Cancer Brain Metastases: Translational Breast Cancer Research Consortium 022.

Elizabeth C. Randall, E. Winer, N. Ibrahim, 2020, Clinical breast cancer.

Translational Breast Cancer Research Consortium 022: Pre- and Post-operative Neratinib for HER2-positive Breast Cancer Brain Metastases

Elizabeth C. Randall, E. Winer, N. Ibrahim, 2020 .

TBCRC 022: A Phase II Trial of Neratinib and Capecitabine for Patients With Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer and Brain Metastases

E. Winer, N. Ibrahim, R. Gelman, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PALB2 mutations in familial breast and pancreatic cancer

P. Miron, K. Nathanson, J. Garber, 2011, Familial Cancer.

Translational Breast Cancer Research Consortium 022: Pre- and Post-operative Neratinib for HER2-positive Breast Cancer Brain Metastases

Elizabeth C. Randall, E. Winer, N. Ibrahim, 2020 .